Cargando…

Interstitial Lung Disease Associated with Lung Cancer: A Case–Control Study

Interstitial lung disease (ILD) seems to be associated with an increased risk of lung cancer (LC) and to have a poorer prognosis than LC without ILD. The frequency of ILD in an LC cohort and its prognosis implication need to be better elucidated. This retrospective, observational, cohort study evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibiot, Quentin, Monnet, Isabelle, Levy, Pierre, Brun, Anne-Laure, Antoine, Martine, Chouaïd, Christos, Cadranel, Jacques, Naccache, Jean-Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141363/ https://www.ncbi.nlm.nih.gov/pubmed/32150840 http://dx.doi.org/10.3390/jcm9030700

Ejemplares similares

Interstitial Lung Disease in Werner Syndrome: A Case Report of a 55-Year-Old Male Patient
por: Goletto, Tiphaine, et al.
Publicado: (2015)

First-line management of advanced non-small-cell lung cancer: can we do better?
por: Chouaïd, Christos, et al.
Publicado: (2023)

Second-line therapy for disseminated small-cell lung cancer: optimal management remains to be defined
por: Chouaïd, Christos, et al.
Publicado: (2020)

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer
por: Cadranel, Jacques, et al.
Publicado: (2019)

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
por: Kewalramani, Namrata, et al.
Publicado: (2022)

Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting
por: Assié, Jean-Baptiste, et al.
Publicado: (2023)

Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer
por: Makris, Demosthenes, et al.
Publicado: (2007)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)
por: Christos, Chouaid, et al.
Publicado: (2012)

Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma
por: Bylicki, Olivier, et al.
Publicado: (2020)

Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma
por: Duruisseaux, Michaël, et al.
Publicado: (2017)

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma
por: Duruisseaux, Michaël, et al.
Publicado: (2016)

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease
por: Le Gouellec, Noémie, et al.
Publicado: (2017)

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
por: Costantini, Adrien, et al.
Publicado: (2018)

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review
por: Chouaïd, Christos, et al.
Publicado: (2014)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
por: Bylicki, Olivier, et al.
Publicado: (2020)

Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC
por: Lesueur, Paul, et al.
Publicado: (2018)

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung
por: Saffroy, Raphaël, et al.
Publicado: (2017)

Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care
por: Bylicki, Olivier, et al.
Publicado: (2019)

The genetics of interstitial lung diseases
por: Borie, Raphael, et al.
Publicado: (2019)

A national internet-linked based database for pediatric interstitial lung diseases: the French network
por: Nathan, Nadia, et al.
Publicado: (2012)

Treatment and Prognosis of Patients with Lung Cancer and Combined Interstitial Lung Disease
por: Mauclet, Charlotte, et al.
Publicado: (2023)

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)
por: Martel-Lafay, Isabelle, et al.
Publicado: (2021)

Predicting outcomes in rheumatoid arthritis related interstitial lung disease
por: Jacob, Joseph, et al.
Publicado: (2019)

Lung transplantation for interstitial lung disease
por: Kapnadak, Siddhartha G., et al.
Publicado: (2021)

Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitors
por: Rozensztajn, Nathalie, et al.
Publicado: (2014)

Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects
por: Gendarme, Sébastien, et al.
Publicado: (2022)

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
por: Gendarme, Sébastien, et al.
Publicado: (2022)

Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system
por: Bermudez, Julien, et al.
Publicado: (2023)

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)
por: Naccache, Jean-Marc, et al.
Publicado: (2019)

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study
por: Scherpereel, Arnaud, et al.
Publicado: (2018)

Interstitial Lung Disease
Publicado: (1982)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2009)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2017)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)
por: Chouaïd, Christos, et al.
Publicado: (2017)

Interstitial Lung Disease in Anti-Synthetase Syndrome
por: Kourkouni, Evangelia, et al.
Publicado: (2019)

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies
por: Berghmans, Thierry, et al.
Publicado: (2021)

Cost analysis of adverse events associated with non-small cell lung cancer management in France
por: Chouaid, Christos, et al.
Publicado: (2017)

Pleuroparenchymal fibroelastosis: a rare interstitial lung disease
por: English, John C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v8ukl8dr1192aokv1btffubr2e